Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Health & Wellness Today New York.
Governor Hochul Speaks at 5BORO NYC Childcare Summit
Earlier today, Governor Hochul spoke at The 5BORO NYC Childcare Summit in Brooklyn to discuss the importance of affordable and accessible child care. The Governor emphasized that a collective effort is needed between state, city, and leaders in...
Owner: American Government
MOH INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Molina Healthcare, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Molina Healthcare, Inc. (“Molina” or “the...
CookUnity Expands Medically Tailored and Chef Created Meals Program to Support Eating Disorder Treatment in Partnership with WithinHealth
The “Food is Medicine” program was launched early this year in New York in partnership with EmblemHealth delivering over 3,000 meals a week to Alzheimer's patients. The program is expanding to support the treatment of eating disorders with...
Mold Water Remediation Announces Completion of Major Restoration Projects in Brooklyn, NY, Including Rockefeller Center and Sofitel Hotel
Brooklyn, NY, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Mold Water Remediation, a licensed and insured restoration company located at 1419 Coney Island Ave, Brooklyn, NY 11230, announced the successful completion of several high-profile restoration...
Presidio Launches Healthcare Vertical with Flagship HealthSense AI Platform
NEW YORK, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Presidio, a leading technology services and solutions provider, today launched its dedicated healthcare vertical, expanding on over a decade of experience with healthcare and life sciences organizations....
AMYLYX INVESTIGATION: Bragar Eagel & Squire, P.C. Urges Amylyx Investors to Contact the Firm Regarding Ongoing Investigation into Amylyx Pharmaceuticals, Inc. on Behalf of Long-Term Stockholders
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Amylyx (AMLX) To Contact Him Directly To Discuss Their Options If you purchased or acquired common stock in Amylyx Pharmaceuticals, Inc....
OKYO Pharma Announces Chairman and Founder Acquires Shares
LONDON and NEW YORK, Oct. 16, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod to treat neuropathic corneal pain (NCP), an ocular condition associated...
MOH COURT ALERT: Did Molina Healthcare, Inc. Mislead Investors? Contact BFA Law by December 2 if You Suffered Losses on Your Investment
NEW YORK, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Molina Healthcare, Inc. (NYSE: MOH) and certain of the Company’s senior executives for potential...
AVITA MEDICAL INVESTIGATION: Bragar Eagel & Squire, P.C. Reminds AVITA Medical Investors to Contact the Firm Regarding the Ongoing Investigation on Behalf of Stockholders
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Avita (RCEL) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in Avita and would like to discuss your...
CVS INVESTIGATION: Bragar Eagel & Squire, P.C. Continues Investigation into CVS Health Corporation on Behalf of Long-Term Stockholders and Urges Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In CVS (CVS) To Contact Him Directly To Discuss Their Options If you are a long-term stockholder in CVS between May 3, 2023 and April 30, 2024...
RAPT Therapeutics Announces Proposed Public Offering of Common Stock
SOUTH SAN FRANCISCO, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT) (“RAPT”), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for...
Autonomix Medical, Inc. to Highlight Innovative Nerve-Sensing and Ablation Platform at the 2025 Maxim Growth Summit
THE WOODLANDS, TX, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced it will participate at...
MediBeacon receives regulatory approval to sell the Transdermal GFR System in China
MediBeacon® Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function The TGFR will be available for sale in China before the end of the year NEW...
Senti Bio to Present at Chardan's 9th Annual Genetic Medicines Conference
SOUTH SAN FRANCISCO, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit...
Faruqi & Faruqi Reminds Molina Healthcare Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 2, 2025 - MOH
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Molina To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Molina between February 5, 2025...
Dianthus Therapeutics Announces Exclusive License Agreement with Leads Biolabs for DNTH212, a First and Potentially Best-In-Class, Phase 1 Ready Bifunctional BDCA2 & BAFF/APRIL Inhibitor for Severe Autoimmune Diseases
DNTH212 is a bifunctional fusion protein targeting plasmacytoid dendritic cell (pDC) BDCA2 to reduce Type 1 interferon production, while simultaneously inhibiting BAFF/APRIL to suppress B cell function Demonstrated superior inhibition of pDCs vs....
Faruqi & Faruqi Reminds Nutex Health Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 21, 2025 - NUTX
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Nutex To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Nutex between August 8, 2024 and...
Faruqi & Faruqi Reminds ATyr Pharma Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 9, 2025 - ATYR
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In ATyr To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in ATyr between January 16, 2025 and...
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Molina Healthcare, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MOH
NEW YORK, Oct. 15, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Molina Healthcare, Inc. (NYSE: MOH) between February 5,...
NUTX DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Nutex Health Inc. Investors to Secure Counsel Before Important October 21 Deadline in Securities Class Action - NUTX
NEW YORK, Oct. 15, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nutex Health Inc. (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025, both dates inclusive (the “Class...